Relationship between cathepsin K and total oxidative state in diabetes mellitus female patients with osteoporosis in Iraq
Keywords:Cathepsin K, TOS, T2DM, OP
Introduction and Aim: Diabetes mellitus patients almost always struggle with a metabolic condition known as chronic hyperglycemia. According to the World Health Organization, osteoporosis is a progressive systemic skeletal disorder that is characterized by decreasing bone mass and microstructural breakdown of bone tissue that increases susceptibility to fracture and increased risk of breaking a bone. Here, we aimed to compare the levels of CatK and total oxidative state in patients with diabetes and osteoporosis among the female Iraqi population and study the possible relationship between them.
Materials and Methods: This study included 40 females with diabetes (Group G1), 40 with diabetes and osteoporosis (Group G2) and 40 normal healthy females (Group G3) as controls. All participants were checked for their height, weight and BMI. Blood drawn from everyone was analyzed for fasting blood sugar, HbA1c, Cathepsin K, TOS, TAC and MDA. Data obtained was subjected to statistical analysis.
Results: According to the findings, the levels of cathepsin K increased significantly (P 0.001) from Group 1 to Groups 2 and 3, as measured by their mean and standard deviation values. The results of total oxidant status, expressed as means and standard deviations (Mean SD), demonstrated a high significant (P 0.001) decline from group G1 to groups G2 and G3.
Conclusion: Cathepsin K was observed to be linked to both type 2 diabetes and bone loss. In postmenopausal Iraqi women with type 2 diabetes, Cathepsin K may serve as a biomarker for both diabetes and osteoporosis.
Jaid, H.K., Khaleel, F.M., Salman, I.N., Abd, B.A. Evaluation of insulin resistance and glutathione-s-transferase in Iraqi patients with type 2 diabetes mellitus and diabetic peripheral neuropathy; Ibn AL-Haitham Journal For Pure and Applied Sciences.2022; 35(4): 194-205.
Jafer, A.A., Ali, B.H., Comparative study of sclerostin and lipid profile in type 2 diabetic patients of Iraqi women with osteoporosis; The Egyptian Journal of Hospital Medicine.2022; 89(2):7535-7541.
Al-Rubaei, Z.M., Abdulhadi, G.H., Alrubaye, I. M. M., Alrugaibi, A.H. Comparative study of fetuin-a levels l Iraqi diabetic patients with hyper and thyroid disorder. Biochemical and Cellular Archives, 2021, 21(1):53–57
Ahmed, S., Shafeeq, N.K. A study of hepcidin levels and other biochemical parameters in women with osteoporosis with type 2 diabetes mellitus; Ibn AL-Haitham Journal for Pure and Applied Sciences.2022; 35(4): 183-193.
Ha, J.Y., Choi, E.Y. Health perception, health concern, and health promotion behavior of the elders; Journal of Korean Gerontological Nursing. 2013;15(3): 277-285.
Schwartz, A.V., Sellmeyer, D.E., Ensrud, K.E., Cauley, J.A., Tabor, H.K., Schreiner, P.J., et al., Older women with diabetes have an increased risk of fracture: a prospective study; The Journal of clinical endocrinology & metabolism. 2001; 86(1): 32-38.
Patel, S., Homaei, A., El-Seedi, H.R., Akhtar, N. Cathepsins: Proteases that are vital for survival but can also be fatal; Biomedicine & Pharmacotherapy.2018; 105:526-532.
Adams-Cioaba, M.A., Krupa, J.C., Xu, C., Mort, J.S., Min, J. Structural basis for the recognition and cleavage of histone H3 by cathepsin L; Nature communications.2011; 2(1): 197. doi: 10.1038/ncomms1204.
Chen, R.P., Ren, A., Ye, S.D. Correlation between serum cathepsin S and insulin resistance in type 2 diabetes; Experimental and Therapeutic Medicine.2013 ;6(5):1237-1242.
Ding, L., Houben, T., Oligschlaeger, Y., Bitorina, A.V., Verwer, B.J., Tushuizen, M.E. Plasma cathepsin D activity rather than levels correlates with metabolic parameters of type 2 diabetes in male individuals. Frontiers in Endocrinology.2020; 11: 575070.
Lee, J.H., Kim, J.H., Hong, A.R., Kim, S.W., Shin, C.S. Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes. The Korean Journal of Internal Medicine.2020; 35(6): 1432-1442.
Park, S.K., Jung, J.Y., Oh, C.M., Choi, J.M., Kim, M.H., Ha, E., et al., Fasting glucose level and the risk of incident osteoporosis in the Koreans. Bone.2021; 142:115690.
Fang, L., Zhong, S., Ma, D., Li, C., Hao, Y., Gao, Y., et al., A cross-sectional study: an assessment of low muscle mass and osteoporosis in type 2 diabetes mellitus patients with a high glycated hemoglobin level; Therapeutic Advances in Chronic Disease.2021; 12: 1-10.
Lecaille, F., Bromme, D. Lalmanach, G. Biochemical properties and regulation of cathepsin K activity .Biochimie. 2008; 90)2(: 208-226.
Guo, R., Hua, Y., Rogers, O., Brown, T.E., Ren, J., Nair, S. Cathepsin K knockout protects against cardiac dysfunction in diabetic mice. Scientific reports. 2017; 7(1): 1-14.
Adolf, D., Wex, T., Jahn, O., Riebau, C., Halangk, W., Klose, S., et al., Serum cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre-and postmenopausal women. Maturitas.2012; 71(2): 169-172.
Altindag, O., Erel, O., Soran, N., Celik, H., Selek, S. Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis. Rheumatology International.2008; 28: 317-321.
Korkmaz, V., Kurdoglu, Z.E.H.R.A., Alisik, M., Turgut, E., Sezgin, O.O., Korkmaz, H.I.L.A.L., et al., Thiol/disulfide homeostasis in postmenopausal osteoporosis. Journal of Endocrinological Investigation. 2017; 40: 431-435.
Rani, A.J., Mythili, S. Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus. Journal of Clinical and Diagnostic Research.2014; 8(3):108-110.
Braxas, H., Rafraf, M., Hasanabad, S.K., Jafarabadi, M.A. Effectiveness of genistein supplementation on metabolic factors and antioxidant status in postmenopausal women with type 2 diabetes mellitus. Canadian Journal of Diabetes.2019; 43(7):490-497.
Barrera, G., Pizzimenti, S., Daga, M., Dianzani, C., Arcaro, A., Cetrangolo, G.P., et al., Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders. Antioxidants.2018; 7(8):102.
Jusup, I., Batubara, L., Ngestiningsih, D., Fulyani, F., Paveta, D.A. Bancin, P.T.L.A. Association between malondialdehyde, GSH/GSSG ratio and bone mineral density in postmenopausal women; Molecular and Cellular Biomedical Sciences.2021; 5(1):13-17.
Jusup, I., Bancin, P. T. L., Jaeri, S. ., Rachmawati, B. The comparison of plasma malondialdehyde levels among osteoporotic and non-osteoporotic postmenopausal women. Journal Kedokteran Diponegoro (Diponegoro Medical Journal).2020; 9(6):495-499.
Manohar, S. M., Vaikasuvu, S.R., Deepthi, K., Sachan, A., Narasimha, S. R. P.V.L., An association of hyperglycemia with plasma malondialdehyde and atherogenic lipid risk factors in newly diagnosed Type 2 diabetic patients. Journal of Research in Medical Sciences. The Official Journal of Isfahan University of Medical Sciences.2013; 18(2):89-93.
How to Cite
Copyright (c) 2023 Biomedicine
This work is licensed under a Creative Commons Attribution 4.0 International License.